000525 Stock Overview
Engages in the research, manufacture, and sale of pesticides and other chemicals in China.
Snowflake Score | |
---|---|
Valuation | 1/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 3/6 |
Dividends | 0/6 |
Nanjing Red Sun Co.,Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CN¥8.37 |
52 Week High | CN¥9.38 |
52 Week Low | CN¥4.88 |
Beta | -0.14 |
11 Month Change | 38.12% |
3 Month Change | 22.19% |
1 Year Change | -6.90% |
33 Year Change | 107.69% |
5 Year Change | -27.09% |
Change since IPO | 444.94% |
Recent News & Updates
Is Nanjing Red SunLtd (SZSE:000525) A Risky Investment?
Aug 09Why Investors Shouldn't Be Surprised By Nanjing Red Sun Co.,Ltd.'s (SZSE:000525) 25% Share Price Plunge
May 13Shareholder Returns
000525 | CN Chemicals | CN Market | |
---|---|---|---|
7D | 24.9% | -0.3% | -0.7% |
1Y | -6.9% | -26.6% | -19.1% |
Return vs Industry: 000525 exceeded the CN Chemicals industry which returned -26.6% over the past year.
Return vs Market: 000525 exceeded the CN Market which returned -19.1% over the past year.
Price Volatility
000525 volatility | |
---|---|
000525 Average Weekly Movement | 7.2% |
Chemicals Industry Average Movement | 5.3% |
Market Average Movement | 5.6% |
10% most volatile stocks in CN Market | 8.9% |
10% least volatile stocks in CN Market | 3.8% |
Stable Share Price: 000525's share price has been volatile over the past 3 months.
Volatility Over Time: 000525's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of CN stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1991 | 2,918 | Fu Ming Zhao | www.chinaredsun.com |
Nanjing Red Sun Co.,Ltd. engages in the research, manufacture, and sale of pesticides and other chemicals in China. The company offers herbicides, insecticides, fungicides, disinfectants, and three-drug intermediates, as well as fine chemicals.
Nanjing Red Sun Co.,Ltd. Fundamentals Summary
000525 fundamental statistics | |
---|---|
Market cap | CN¥4.86b |
Earnings (TTM) | -CN¥380.36m |
Revenue (TTM) | CN¥3.33b |
1.5x
P/S Ratio-12.8x
P/E RatioIs 000525 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
000525 income statement (TTM) | |
---|---|
Revenue | CN¥3.33b |
Cost of Revenue | CN¥3.18b |
Gross Profit | CN¥148.10m |
Other Expenses | CN¥528.46m |
Earnings | -CN¥380.36m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Aug 31, 2024
Earnings per share (EPS) | -0.65 |
Gross Margin | 4.45% |
Net Profit Margin | -11.42% |
Debt/Equity Ratio | 424.9% |
How did 000525 perform over the long term?
See historical performance and comparison